Short Interest in ReWalk Robotics Ltd. (NASDAQ:LFWD) Expands By 214.2%

ReWalk Robotics Ltd. (NASDAQ:LFWD) was the target of a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 2,510,000 shares, a growth of 214.2% from the February 28th total of 798,900 shares. Based on an average daily volume of 2,450,000 shares, the days-to-cover ratio is presently 1.0 days. Currently, 26.8% of the shares of the stock are short sold.

ReWalk Robotics Price Performance

Shares of NASDAQ LFWD traded down $0.09 during trading hours on Friday, reaching $1.79. The stock had a trading volume of 286,689 shares, compared to its average volume of 669,199. The business’s fifty day moving average is $1.67 and its two-hundred day moving average is $2.10. The company has a market cap of $19.03 million, a price-to-earnings ratio of -0.72 and a beta of 1.73. ReWalk Robotics has a twelve month low of $1.25 and a twelve month high of $6.00.

ReWalk Robotics (NASDAQ:LFWD) last issued its quarterly earnings data on Friday, March 7th. The company reported ($1.73) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.20) by ($1.53). The company had revenue of $7.55 million for the quarter, compared to the consensus estimate of $7.30 million. ReWalk Robotics had a negative net margin of 77.21% and a negative return on equity of 43.02%. Sell-side analysts forecast that ReWalk Robotics will post -1.78 earnings per share for the current fiscal year.

Insider Buying and Selling

In other ReWalk Robotics news, major shareholder Global Fund Lp Lind II sold 381,676 shares of the business’s stock in a transaction on Monday, January 6th. The shares were sold at an average price of $3.36, for a total transaction of $1,282,431.36. Following the sale, the insider now directly owns 1,049,430 shares of the company’s stock, valued at $3,526,084.80. The trade was a 26.67 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 2.50% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently issued reports on LFWD. Laidlaw initiated coverage on ReWalk Robotics in a research note on Monday, February 10th. They set a “buy” rating and a $10.00 price target for the company. Lake Street Capital lowered their target price on shares of ReWalk Robotics from $4.50 to $4.00 and set a “buy” rating on the stock in a research note on Tuesday, March 11th. Finally, HC Wainwright reissued a “buy” rating and set a $13.00 target price on shares of ReWalk Robotics in a research report on Tuesday, March 11th.

ReWalk Robotics Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.